Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 144,767 | 129,620 | 127,013 | 123,549 | 83,751 |
| Cost of Goods | 67,365 | 79,831 | 68,174 | 71,185 | 35,255 |
| Gross Profit | 77,402 | 49,789 | 58,839 | 52,364 | 48,496 |
| Operating Expenses | 53,140 | 38,863 | 38,546 | 41,439 | 58,766 |
| Operating Income | 24,627 | 11,757 | 20,467 | 11,110 | -10,015 |
| Interest Expense | 21,427 | 20,575 | 19,046 | 17,761 | 5,831 |
| Other Income | -20,757 | 1,027 | 11 | 5 | 4 |
| Pre-tax Income | -17,557 | -7,791 | 1,432 | -6,646 | -15,842 |
| Income Tax | -131 | -592 | 975 | -1,455 | -2,773 |
| Net Income Continuous | -17,426 | -7,199 | 457 | -5,191 | -13,069 |
| Net Income | $-17,426 | $-7,199 | $457 | $-5,191 | $-13,069 |
| EPS Basic Total Ops | -0.51 | -0.21 | 0.01 | -0.15 | -0.39 |
| EPS Basic Continuous Ops | -0.51 | -0.21 | 0.01 | -0.15 | -0.39 |
| EPS Diluted Total Ops | -0.51 | -0.21 | 0.01 | -0.15 | -0.39 |
| EPS Diluted Continuous Ops | -0.51 | -0.21 | 0.01 | -0.15 | -0.39 |
| EBITDA(a) | $62,910 | $54,861 | $58,507 | $49,267 | $9,623 |